Product Information

METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Laurus Labs Limited, priced at $0.0508 per EA under NDC 42385097801. Its NADAC has been published 124 times since Jul 3, 2024.

FDA first approved this application on Oct 5, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL ER 750 MG TABLET

METFORMIN HYDROCHLORIDE
$0.0508per EA

Strength

750 mg/1

NDC

42385097801

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217631

FDA Approved

10/5/2023

TE Code

AB1

On Market Since

10/6/2023

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 124 times since Jul 3, 2024, and over the history we have for it it has declined 26.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0508 per EA
All-time high$0.0731 (Oct 16, 2024)
All-time low$0.0508 (Oct 21, 2026)
52-week high$0.0566
52-week low$0.0508
Median price$0.0553
Average price$0.0569
Largest weekly change-20.8% (Jul 17, 2024)
Weeks tracked124
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

-3.6%

3M

-7.4%

6M

-8.8%

1Y

-4.4%

3Y

N/A

5Y

N/A

All

-26.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Laurus Labs Limited, is $0.0508 per EA (NDC 42385097801), effective Nov 11, 2026.

How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 26.4%. It has been tracked across 124 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?

Since Jul 3, 2024, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0508 (Oct 21, 2026) to a high of $0.0731 (Oct 16, 2024), with a median of $0.0553 per EA.

Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL ER 750 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL ER 750 MG TABLET?

METFORMIN HCL ER 750 MG TABLET (NDC 42385097801) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.